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Upon dimerization by oxidation, Hsp33 functions as a molecular chaperone in prokaryotes. Previ-
ously published structures of both the inactive and active species are of doubtful relevance to the
solution conformations since the inactive (reduced) crystal structure was dimeric, while the active
(oxidized) species was crystallized with a truncation of its regulation domain. The interdomain con-
tact site of the inactive monomer, identiﬁed in this work, is consistent with that previously observed
in the reduced dimer crystal. In contrast, ﬂuorescence quenching of the active dimer contradicted
the results expected from the domain-swapped fold observed in the truncated dimer crystal. The
results of this study provide important new information concerning controversial issues in the acti-
vation process of Hsp33.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hsp33 is a prokaryotic molecular chaperone that protect cells
from severe oxidative stress [1,2]. While the expression of Hsp33
is regulated by heat-shock exposure, its activation is achieved at
a post-translational level and depends upon the cellular redox
potential. Activated Hsp33, in response to oxidative stress, exerts
a holdase activity that binds the folding intermediates of substrate
proteins and prevents their ultimate, irreversible denaturation.
Under normal, reducing conditions, Hsp33 behaves as an inactive
monomer and it adopts a dimerized structure upon oxidation.
Mutational studies have suggested that dimerization is not a criti-
cal aspect in the process by which Hsp33 achieves chaperone func-
tionality [3,4], but partially oxidized Hsp33, which retains in a
monomeric state, is thought to be inactive [5,6]. Thus, the smallest
unit of active, wild-type Hsp33 is an oxidized dimer, although
oxidized Hsp33 can also form larger oligomers, which seem to
exhibit more potent chaperone activity [7].chemical Societies. Published by E
yon Pharmaceutical Co., Ltd.,The activation process is triggered by oxidation of the C-termi-
nal domain, a zinc-containing, redox switch [8]. Upon oxidation,
four conserved cysteines that coordinate the zinc ion form two
disulﬁde bonds, thereby releasing the zinc ion. Releasing the zinc
ion results in the unfolding of the redox-switch domain [9], which
is followed by dimerization of the entire protein and the exposure
of a hydrophobic substrate-binding site [4,5]. The crystal structure
of oxidized Escherichia coli Hsp33 (EcHsp33), in which the redox-
switch domain had been truncated during crystallization, showed
a domain-swapped dimer fold (Fig. 1A) [10,11]. The crystal struc-
tures of intact, reduced Hsp33 from Bacillus subtilis (BsHsp33)
[12] and from Thermotoga maritima [13] provided important infor-
mation on the interdomain contact site of the redox-switch
domain. However, working models of the Hsp33 activation process
are still the subject of much controversy, as the crystal structures
of both active and inactive species contain features that conﬂict
with biochemical ﬁndings in solution. First, the domain-swapped
fold observed in the oxidized dimer crystal has not been observed
in solution or in the intact protein crystal [14], and conﬂicts with a
recent model for Hsp33 activation, which suggests that the
domain-swapped region unfolds [5]. Second, the crystal structure
of the reduced form was dimerized (Fig. 1B), whereas the protein
is a monomer in its inactive state in solution [15,16]. Since alsevier B.V. All rights reserved.
Fig. 1. Domain organization in the crystal structures of Hsp33 from E. coli (A) and
from B. subtilis (B) (PDB code 1I7F and 1VZY, respectively; drawn using UCSF
Chimera program [22]). Each domain of one polypeptide chain in a dimer is colored
differently: blue, magenta, and green for the N-terminal core domain, middle linker
domain, and the C-terminal redox-switch domain, respectively. The zinc ion is
depicted as a yellow ball. Sidechains of W212 residues (A) and the interdomain
contact site of the redox-switch domain (B), identiﬁed in this study, are presented
in red.
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reduction of substrate-bound Hsp33 [12,17], the domain contact
site in the reduced Hsp33 dimer crystal cannot be conclusively said
to be representative of the inactive monomer in solution. In this
study, we aimed to clarify these doubtful aspects of the crystal
structures of active and inactive Hsp33: the interdomain-contact
site in the inactive monomer and the domain-swapped fold in
the active dimer. The present results in solution validate those
found previously in regard to the inactive monomer but con-
tradicted those found in regard to the active dimer, providing use-
ful information to inspect current working models of the activation
process of Hsp33.2. Materials and methods
2.1. Protein preparation
Recombinant plasmids for protein expression [2,9] were gener-
ously provided by Drs. Ursula Jakob (University of Michigan, USA)
and H. Jane Dyson (The Scripps Research Institute, USA). Both the
redox-switch domain (residues 227–287) and full-length (residues1–294) EcHsp33 were prepared in their reduced, zinc-bound forms
as described previously [9,16]. After oxidation by H2O2, the three
kinds of oxidized EcHsp33 species were separated and identiﬁed
(refer to the Supplementary material): an oxidized oligomer, an
oxidized dimer, and a half-oxidized monomer. For NMR, isotope-
enriched proteins were also prepared in their reduced, zinc-bound
forms, as described previously [9,16]: [15N] EcHsp33(227–287) and
[2H, 13C, 15N] EcHsp33(1–294).
2.2. NMR spectroscopy
NMR spectra of 0.6 mM protein dissolved in a 20 mM Tris–HCl
buffer (pH 7.4) containing 50 mM NaCl, 5 mM DTT, and 50 lM
ZnSO4 were obtained at 298 K on a Bruker Biospin Avance 900
spectrometer equipped with a cryoprobe. Conventional 2D-[1H,
15N]-TROSY spectra were recorded for both the full-length EcHsp33
and EcHsp33(227–287). 3D-HNCA and HN(CO)CA spectra of the
full-length EcHsp33 were measured in a TROSY type. Chemical
shifts were referenced directly to DSS for 1H and indirectly for
15N and 13C atoms using the chemical shift ratios suggested in
the BMRB (http://www.bmrb.wisc.edu). Chemical shift perturba-
tions were evaluated as their weighted average variations (DAVE),
using the 1HN (DdH) and 15Na (DdN) chemical shifts [18]:
DAVE ¼ ½ðDd2H þ Dd2N=25Þ=21=2.
2.3. Fluorescence spectroscopy
Fluorescence of 5 lM EcHsp33 dissolved in 40 mM HEPES-KOH
buffer (pH 7.5) was monitored using a Varian Cary Eclipse ﬂuorom-
eter at 25 C. An excitation wavelength of 295 nm was used with a
5 nm excitation bandwidth. Emission scans were taken from 300 to
450 nm, with a 10 nm emission bandwidth and a 0.5 nm data
interval. Fluorescence emission was then quenched by the progres-
sive addition (1 ll at a time) of a 5.5 M acrylamide to the 0.5 ml
sample solution, to a ﬁnal concentration of 0.1 M. Emission inten-
sities at kmax were acquired as a function of quencher concentra-
tion ([Q]) and ﬁt to the Stern–Volmer equation [19]: F0/
F = 1 + KSV[Q], where F0 and F are ﬂuorescence intensities in the
absence and presence of the quencher, and KSV is the dynamic
(Stern–Volmer) quenching constant.
3. Results
3.1. The interdomain contact site of the inactive monomer
The NMR structure of the isolated redox-switch domain,
Hsp33(227–287) [9] is consistent with the crystal structures of
full-length Hsp33. In this study, the 2D-[1H, 15N]-TROSY spectrum
of EcHsp33(227–287) was compared with that of full-length
(1-294) EcHsp33 (Fig. 2A). Resonances from the EcHsp33(227–
287) were assigned according to previous assignment data (BMRB
accession number 6332). Each of the shifted peaks in the full-length
EcHsp33 spectrumwas then traced through conﬁrmationof the 13Ca
resonance connectivity in the 3D-HNCA and HN(CO)CA spectra of
full-length EcHsp33. Finally, except for the two N-terminal residues
of the isolated redox-switch domain, D227 and V228, which could
not be veriﬁed in the full-length EcHsp33 spectrum, all of the reso-
nances from the redox-switch domain were unambiguously
assigned in both constructs. Chemical shift perturbations (CSPs)
were calculated for the assigned resonances and plotted along the
amino acid sequence, as shown in Fig. 2B. It was reasonable to
expect large CSPs at the N- and C-termini of EcHsp33(227–287)
due to differences in the sizes of the two constructs: 227–287 vs.
1–294 residues. However, in addition to the terminal residues, we
identiﬁed two speciﬁc regions with appreciable CSP (0.06 ppm or
more): residues F230 to S235 and H264 to G269. The observed CSPs
Fig. 2. Identiﬁcation of the interdomain contact site. (A) Superimposition of the
[1H,15N]-TROSY spectra of Hsp33(227–287) (red) and full-length Hsp33 (black).
Shifted peaks are indicated by blue lines or circles. (B) Chemical shift perturbations
between Hsp33(227–287) and full-length Hsp33.
Fig. 3. Fluorescence of RedHsp33M (blue), pOxHsp33M (red), OxHsp33Di (green) and
OxHsp33Oli (black). (A) Fluorescence emission spectra in the absence of the
quencher, acrylamide. Six scans were added and averaged, followed by subtraction
of the solvent (blank) spectrum. (B) Stern–Volmer plots with the linear least square
ﬁtting (solid lines) of each data set (symbols) plotted. Inset illustrates the spectral
quenching of RedHsp33M, upon progressive addition of acrylamide.
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N-terminal core domain in the intact form. Based on the sequence
alignment between EcHsp33 and BsHsp33, the regions with signiﬁ-
cant CSP were mapped on the crystal structure of the reduced, full-
length BsHsp33 (Fig. 1). Themajority of regions exhibiting high CSPs
were localized around the zinc-binding site, which is composed of
two loop regions constrained by conserved cysteines bound to a zinc
ion. The location was consistent with the interdomain contact site
observed in the crystal structure of the reduced BsHsp33 dimer.
Therefore, these results imply that the interdomain contact site, as
well as the structure of the redox-switch domain in the inactive
Hsp33monomer in solution is identical to that previously observed
in the crystal structure of the reduced dimer.
3.2. The linker domain environment of the oxidized dimer
The linker domain fold is nearly identical in all of the known
crystal structures of Hsp33. EcHsp33 has only one tryptophan res-
idue (W212) in the middle of the linker domain, which is exposed
on the surface (Fig. 1A). Thus, we investigated the tryptophanyl
environment, by ﬂuorescence spectroscopy (Fig. 3 and Table 1) in
order to assess the linker domain structure in solution. Akhtar
et al. [7] previously monitored the intrinsic ﬂuorescence of
EcHsp33 and observed blue shifts in the emission spectra and a
reduction in the quenching constants, upon oxidation of theprotein. However, the oxidized Hsp33 solution usually contains a
mixture of different types of oxidized species. Thus, we separated
individual species (Supplementary material) and measured the
ﬂuorescence spectrum of each species. In addition, an excitation
wavelength of 295 nm was employed to ensure that almost all
the light was absorbed solely by tryptophan, without effects from
tyrosines [20]. The reduced, inactive monomer (RedHsp33M) exhib-
ited an emission kmax of 356 nm, which was in agreement with the
value generally known for solvent-accessible tryptophan [20] and
validates the in solution structure with the fold observed in the
crystal structures. No signiﬁcant difference in kmax was observed
for the half-oxidized Hsp33 monomer (hOxHsp33M), which sup-
ports the suggestion made by Ilbert et al. [5] that the linker domain
fold would have the same structure in both RedHsp33M and
hOxHsp33M. In contrast, kmax was blue-shifted by 5 nm in the fully
oxidized, active dimer (OxHsp33Di) and the oligomer (OxHsp33Oli)
species, indicating that the tryptophan residue moved to a rela-
tively non-polar environment. In addition, the dynamic quenching
constant (KSV) was signiﬁcantly reduced from 14.7 M1, in the
inactive RedHsp33M, to 10.1 M1, in the active OxHsp33Di, indicating
a decrease in solvent accessibility. The KSV of another inactive form
(hOxHsp33M) was consistent with that of RedHsp33M, while another
active species (OxHsp33Oli) had a KSV value comparable with that of
Table 1
The ﬂuorescence emission and quenching parameters of Hsp33.
kmax (nm) KSV (M1)
RedHsp33M 356 ± 0.5 14.7 ± 0.2
hOxHsp33M 356 ± 0.5 14.9 ± 0.2
OxHsp33Di 351 ± 0.5 10.1 ± 0.1
OxHsp33Oli 351 ± 0.5 9.4 ± 0.3
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within the linker domain is initially surface-exposed and becomes
buried in a relatively hydrophobic environment upon the oxida-
tion-induced activation of EcHsp33. This conclusion is consistent
with that by Akhtar et al. [7], and clariﬁes that the change does
not occur in the oxidized monomer and is attributed to dimeriza-
tion and oligomerization. Thus, the ﬂuorescent properties observed
in the active Hsp33 species (OxHsp33Di and OxHsp33Oli) cannot be
explained by the crystal structures of the reduced dimer or the
truncated dimer.
4. Discussion
Although the substrate-binding site of Hsp33 has not yet been
identiﬁed, both research groups who, independently, solved the
crystal structure of EcHsp33 have suggested a concave groove
formed by the set of ﬁve-stranded (b5–b4–b3–b6–b7 in Fig. 1)
b-sheets as the most likely site [3,10,11]. Since the solved struc-
tures have commonly lacked the C-terminal redox-switch domain,
it has been suggested that the redox-switch domain in the inactive,
reduced monomer masked the substrate-binding site [9,11,15,21].
In particular, Vijayalakshmi et al. [11] predicted that the redox-
switch domain would ﬁt in the potential substrate-binding groove,
speciﬁcally through an amphipathic helix region of the domain.
However, later crystal structures of the intact BsHsp33 dimer in a
reduced state showed the location of the redox-switch domain as
ﬂanking the end of the N-terminal core domain [12,13], where only
a small portion of the redox-switch domain, around the zinc-bind-
ing site, was in contact with the edge of the N-terminal domain
(Fig. 1B). While the present NMR results in solution supported this
level of interdomain contact, it is no guarantee of the physiological
relevance of the overall conformation shown in the dimer crystal.
Although the structural properties might be different between
EcHsp33 and BsHsp33, the reduced BsHsp33 is also distinctly
monomeric at least at physiologically relevant concentrations
[12]. Thus, the overall conformation of the reduced dimer crystal
may represent the reduced, but active dimer species that can be
formed in vivo [12,17]. However, we can conclusively state that
the redox-switch domain in the reduced, inactive monomer does
not directly mask the putative substrate-binding site. These results
may imply that the concave groove is not the substrate-binding
site. Otherwise, if the concave groove serves as a substrate-binding
site, then the unfolding of the redox-switch domain would be
required for oligomerization to enlarge the substrate-binding sur-
face. Although some artiﬁcial mutants of Hsp33 were identiﬁed as
an active monomer [3,4], the oxidation-induced dimerization or
oligomerization can be a critical determinant for native Hsp33 to
achieve full activity. It has been shown that native Hsp33 becomes
more potent upon adopting higher-order oligomers [7], while its
oxidized monomer is inactive or just partially active (refer to Sup-
plementary data) [3,5,15,21].
An alternative model, also suggested by Vijayalakshmi et al.
[11] and updated by Ilbert et al. [5], suggests that the cleft running
parallel to the b8 strand (refer to Fig. 1), which can be further elon-
gated by dimerization, presents a suitable substrate-binding site.
For this, unfolding of the linker domain (a5–a6–a7 in Fig. 1), in
addition to the unfolding of the redox-switch domain, would be
directly responsible for conferring activity by fully exposing thepotential substrate-binding site around b8 [4–6]. This model for
activated Hsp33 conﬂicted with the crystal structure of E. coli
Hsp33, which has long been thought to be the active form of
Hsp33 [3,10,11,14]. In the crystal structure of E. coli Hsp33
(Fig. 1A), the linker domain is well-folded and surface-exposed.
This proposed structure seemed to be reasonable, since the linker
domain critically contributed to dimerization via domain swapping
(Fig. 1A). However, the ﬂuorescence experiments in the present
study and in the previous work by Akhtar et al. [7] commonly sug-
gest that the linker domain of active, oxidized Hsp33 is buried in a
hydrophobic environment. While this ﬁnding does not contradict a
domain swapping process during dimerization, it indicates that the
linker domain fold evident in the crystal structure of EcHsp33 is
not relevant to the functionality of the protein in solution. Thus,
the working model described by Ilbert et al. [5] cannot be criticized
based on the known crystal structures. In addition, the ﬂuores-
cence results reported by Ilbert et al. using the F187W/W212F-
doubly mutated EcHsp33 support oxidation-induced unfolding in
the linker domain since an appreciable red shift of the W187 ﬂuo-
rescence emission was observed. However, the blue shift and
reduced quenching of the W212 ﬂuorescence in the wild-type
EcHsp33, which conﬂicts with the red shift of F187W/W212F
mutant, is not explained solely with unfolding. In addition, even
if the previously observed domain swapping was an artifact of
crystallization and/or truncation, the alternative model cannot
explain why and how Hsp33 is dimerized or oligomerized while
in an oxidized state but not in its inactive, reduced state in solu-
tion. To resolve these issues, structural information of the inactive,
reduced Hsp33 monomer in solution is needed. We expect that the
continued effort to solve the NMR structure and molecular dynam-
ics of the reduced Hsp33 monomer will reveal a conclusive activa-
tion process for the protein.Acknowledgements
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